Molecular characterization of epstein‐barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea
- 9 June 2004
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 26 (7) , 573-583
- https://doi.org/10.1002/hed.10370
Abstract
Background. We evaluated the characteristics of nasopharyngeal carcinoma in Korea, including its clinical, pathologic, and molecular features, especially emphasizing on the EBV strains involved, latent membrane protein 1 (LMP1) expression, and the alterations of matrix metalloproteinase 9 (MMP9) and E-cadherin expression. Methods. The presence of EBV was evaluated by EBER in situ hybridization, and the expression of LMP1, MMP9, and E-cadherin by immunohistochemistry. The characterization of EBV type and LMP1 variant was performed by PCR. Results. EBER was detected in 55 of 57 cases (96%) of nonkeratinizing carcinoma (NKC) and undifferentiated carcinoma, but in only four of nine cases (44%) of squamous cell carcinoma (SCC). EBER positivity was much higher in the group with nodal metastases (p = .003). The predominant strain of EBV infection was type A (81%) and a 30-bp deletion LMP1 variant (77%). All EBER-positive SCCs were infected with EBV type A. LMP1 expression was detected in 36 of 59 (61%) patients with latent EBV infection and MMP9 in 41 of these 59 (69%). LMP1 positivity was much higher among the patients aged 50 years and younger. MMP9 expression was associated with LMP1 expression (p = .008), and nodal and distant metastasis (p = .019, p = .045). Loss of E-cadherin expression was correlated with MMP9 and nodal metastasis. The survival rate was much lower in patients with a higher TNM classification, stage, and a histology of SCC. EBER positivity was associated with a better prognosis in the Kaplan-Meier test, but had no prognostic value by Cox regression analysis. Loss of E-cadherin expression and nodal metastasis were also correlated with local recurrence and distant metastasis. Conclusion. EBV type and LMP1 variant had no significant influence on the clinicopathologic properties of tumor. However, there was a tendency toward a better survival in the EBV type B group. Histology and clinical staging were the two most important prognostic factors. © 2004 Wiley Periodicals, Inc. Head Neck 26: 573–583, 2004Keywords
This publication has 20 references indexed in Scilit:
- Comparative analysis of NK/T‐cell lymphoma and peripheral T‐cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30‐bp deletion variant LMP1Pathology International, 2003
- Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1Pathology International, 2003
- Detection of an epstein‐barr‐virus variant in T‐cell‐lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the taiwanese populationInternational Journal of Cancer, 1995
- Sequence variation in the Epstein--Barr virus latent membrane protein 1Journal of General Virology, 1994
- Decreased expression of E‐cadherin and increased invasive capacity in EBV‐LMP‐transfected human epithelial and murine adenocarcinoma cellsInternational Journal of Cancer, 1992
- EBV strain variation: Geographical distribution and relation to disease stateVirology, 1992
- Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytesNature, 1989
- New Type B Isolates of Epstein--Barr Virus from Burkitt's Lymphoma and from Normal Individuals in Endemic AreasJournal of General Virology, 1987
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985